Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

Thursday’s trading has closed, but NVO is being traded in the after-hours session. After-Hours quote »
Delayed Data
As of 4:04pm ET
 +0.13 / +0.24%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 33 analysts offering 12-month price forecasts for Novo Nordisk have a median target of 61.50, with a high estimate of 74.89 and a low estimate of 41.17. The median estimate represents a +12.36% increase from the last price of 54.73.

Analyst Recommendations

The current consensus among 33 polled investment analysts is to Buy stock in Novo Nordisk. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Oct 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -1.91%
Growthannually 19.51%


Growthquarterly 3.05%
Growthannually 11.91%
Key to the earnings and sales forecast charts.